DCTN4, dynactin subunit 4, 51164

N. diseases: 253; N. variants: 4
Disease: Adenocarcinoma ×
Source: ALL
Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
CUI: C0001418
Disease: Adenocarcinoma
Adenocarcinoma 		0.040 Biomarker group BEFREE LC3B and p62 could be used as prognostic biomarkers and potential therapeutic targets for gastric adenocarcinomas. 31810936 2019
CUI: C0001418
Disease: Adenocarcinoma
Adenocarcinoma 		0.040 AlteredExpression group BEFREE Correction: A specific expression profile of LC3B and p62 is associated with nonresponse to neoadjuvant chemotherapy in esophageal adenocarcinomas. 31665193 2019
CUI: C0001418
Disease: Adenocarcinoma
Adenocarcinoma 		0.040 AlteredExpression group BEFREE A specific expression profile of LC3B and p62 is associated with nonresponse to neoadjuvant chemotherapy in esophageal adenocarcinomas. 29897944 2018
CUI: C0001418
Disease: Adenocarcinoma
Adenocarcinoma 		0.040 GeneticVariation group BEFREE Moreover, p62 and VPRBP were associated with poor prognosis in lung ADC (adenocarcinoma) (p62, P=0.019; VPRBP, P=0.005). 22963397 2013